Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth and Caprion Expand Protein Biomarker Agreement

NEW YORK, June 28 (GenomeWeb News) - Wyeth has expanded its protein biomarker collaboration with Caprion Pharmaceuticals to identify disease-state biomarkers in the areas of asthma and renal cell carcinoma, Caprion said today.

 

Under the terms of the agreement, Caprion will conduct proteomic analyses of human blood plasma samples from patients in two separate Phase II clinical trials in asthma and renal cell carcinoma.

 

Wyeth and Caprion had previously collaborated on preclinical biomarker research in inflammatory disease using Caprion's CellCarta protein expression profiling technology, Caprion said. The companies initiated the collaboration in July 2003.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.